Pancreatic Adenocarcinoma Metastatic Clinical Trials in Madrid
2 recruitingMadrid, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 1
Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma Metastatic
Oncomatryx Biopharma S.L.69 enrolled7 locationsNCT07377045
Recruiting
Phase 1Phase 2
TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)
Pancreatic Adenocarcinoma MetastaticPancreatic Ductal Adenocarcinoma
Clinica Universidad de Navarra, Universidad de Navarra30 enrolled5 locationsNCT07284277